Fredun Pharmaceuticals Ltd — Important, 06-08-2026: Company Update

Fredun Pharmaceuticals reported strong financial results for the quarter. Total Income surged 90.44% to ₹228.25 Cr, EBITDA grew 92.90% to ₹32.78 Cr, and Net Profit increased 94.63% to ₹13.17 Cr. Management emphasized that long-term investments are translating into tangible outcomes, building a diversified healthcare company with multiple growth engines. Additionally, the company recently allotted 1.10 Cr Bonus Equity Shares in a 2:1 ratio. This increased issued capital from 0.55 Cr shares to 1.65 Cr shares, reflecting a focus on growth and shareholder value.